Emerging evidence suggests that, compared with canonical methyltransferases, RBM15 may exert a more targeted influence on immune cell fate and anti-tumor responses, highlighting its unique and potentially complementary role in shaping tumor immunity (Wang et al., 2025a). The gene discussed is RBM15; the disease is neoplasm.